Company Quick10K Filing
Medovex
10-Q 2020-03-31 Filed 2020-05-21
10-K 2019-12-31 Filed 2020-04-22
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-10
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-11
10-K 2017-12-31 Filed 2018-03-30
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-17
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-31
8-K 2020-05-13
8-K 2020-04-15
8-K 2020-04-02
8-K 2020-03-27
8-K 2020-01-21
8-K 2019-12-06
8-K 2019-11-21
8-K 2019-11-01
8-K 2019-10-02
8-K 2019-07-31
8-K 2019-07-15
8-K 2019-06-26
8-K 2019-06-17
8-K 2019-04-30
8-K 2019-04-05
8-K 2019-03-15
8-K 2019-02-15
8-K 2019-02-08
8-K 2019-01-25
8-K 2019-01-14
8-K 2018-12-21
8-K 2018-10-18
8-K 2018-10-15
8-K 2018-05-09
8-K 2018-03-01
8-K 2018-02-06

Medovex Financials

MDVX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CCUR (CCUR) 42,638 0% 7.9 6% 65,998 9,965 5,021 0 4,245 4,508 35,471
Smartag International (SMRN) 42,619 100% -140.1 -347% 87 31 1 1 -304 -304 42,532
Mastermind (MMND) 42,338 88% 91.3 16% 2,419 256 3,727 3,297 375 459 41,906
Newgioco (NWGI) 42,058 0% -17.6 -21% 25,358 17,927 25,127 0 -5,400 -2,117 37,352
Parallax Health Sciences (PRLX) 41,922 280% -5.4 -333% 2,373 7,209 82 229 -7,914 -7,871 42,507
Sanuwave Health (SNWV) 41,781 42% -5.8 -467% 1,644 14,962 693 290 -7,680 -7,149 41,378
ATI Nationwide Holding (ATIN) 41,622 -862.6 -3,752% 1 19 0 0 -48 -48 41,621
India Globalization Capital (IGC) 40,759 2% -5.1 -16% 32,887 1,645 6,297 141 -5,284 -5,207 26,696
Portsmouth Square (PRSI) 40,747 24% 13.7 4% 62,481 135,874 59,500 14,496 2,290 12,407 169,553
Medovex (MDVX) 40,687 75% -3.7 -66% 17,580 8,020 6,498 4,897 -11,616 -10,904 40,342
MJ Holdings (MJNE) 40,433 31% -12.8 -27% 11,993 5,152 779 240 -3,278 -3,125 39,929
Barfresh (BRFH) 40,406 56% -16.8 -60% 6,592 4,566 3,782 2,137 -3,950 -2,523 42,352
EPHS Holdings (STNN) 40,182 -65.5 -21% 3,196 2,664 0 0 -658 -638 41,794
Pharmacyte Biotech (PMCB) 39,956 -9.9 -75% 5,338 804 0 0 -4,016 -4,016 39,911
Guardion Health Sciences (GHSI) 39,881 61% -5.4 -76% 8,955 906 665 403 -6,819 -6,353 34,326
Super League Gaming (SLGG) 39,507 54% -1.1 -138% 18,773 1,567 822 443 -25,991 -25,147 26,921
Smith Midland (SMID) 39,433 20% 13.6 3% 40,403 20,126 34,250 6,971 1,178 2,992 40,678
Earth Science Tech (ETST) 39,246 53% -19.3 -600% 352 833 597 316 -2,113 -2,030 39,211
Xspand Products Lab (XSPL) 38,927 30% -18.2 -24% 9,639 4,622 7,819 2,365 -2,304 -2,080 37,914
First Choice Healthcare Solutions (FCHS) 38,514 16.2 3% 27,801 7,984 0 0 832 1,917 31,130

Balance Sheet ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5,0293,2191,7711,5704712889148931,9937491,931245126114228472,592300368
Accounts Receivable33095157171156141146761437
Inventory2222256179295306294206131129129126
PP&E323333353839401191221299213513513513565651663667
Assets15,68113,53312,07411,53210,2451,9462,9821,5082,4021,1902,5991,22892678471440413,28216,72617,580
Accounts Payable5611581192782111811982262211022691965114936897519417171,952
Long-Term Debt260251237165150170392260023
Liabilities1,0607206321,5096896351,6071,9565063955925151,0959921,8142,4014,1314,7728,020
Stockholders' Equity14,62012,81311,44210,0239,5561,3121,375-4481,8957942,021713-169-207-1,101-1,9979,15111,9549,561
Income Statement ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000330000117901442522091,3242,4322,742
Cost of Revenue838099205122559492550
Gross Profit34104555847651,9402,192
R&D305328249581892333963543355670291398546
SG&A1,1501,5331,1981,1191,1521,1411,3381,7141,5051,3631,3091,6021,1471,1021,1594,156
Tax
Net Income-1,454-1,861-1,447-1,758-1,832-9,544-1,809-3,043-2,239-1,236-1,354-1,629-1,254-986-1,172-3,695-5,297-2,624
Cash Flow ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,239-2,144-1,431-1,168-1,055-1,317-1,637-1,418-1,455-1,199-1,268-1,668-825-793-498-4,171-2,421-1,315
Cash Investing-1,500343-31-3-2-1421-3-7-4-215000-377-9-4
Cash Financing1,084-9-14966-401,1362,2649762,558-372,454-165567816127,0701381,387